Article
Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups
8 Sept 2015
Abstract excerpt
BACKGROUND: Tumour classification, based on histopathology or molecular pathology, is of value to predict tumour behaviour and to select appropriate treatment. In retinoblastoma, pathology information is not available at diagnosis and only exists for enucleated tumours. Alternative methods of tumour classification, using noninvasive techniques such as magnetic resonance spectroscopy, are urgently required to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
